Min Jun

About Associate Professor Min Jun

Program Lead

Min Jun is Scientia Associate Professor and Program Lead at the George Institute for Global Health, Faculty of Medicine, UNSW Sydney.

Min leads a program of research focused on understanding the impact of clinical management strategies in people with kidney disease and its related complications. He has developed and leads international projects using large clinical trial and real-world, population based data sources.

Min holds a PhD (2012) and MScMed(ClinEpi) in clinical epidemiology from the University of Sydney, and a MSc(by research) and BSc(Hon) from UNSW Sydney. He was previously an NHMRC Early Career Fellow (2013-2016) based in Canada (University of Calgary), co-funded by two additional competitive federal/provincial Canadian fellowships (CIHR/AIHS). Min's research track record includes >100 publications (including in top-ranked journals e.g. BMJ, Lancet, JACC), >$5.1M in research funding from top-level funding agencies (e.g. NHMRC). To date, 72% of his work is published in top 10% journals worldwide, has been cited >4500 times including in some 24 international clinical practice guidelines across various fields.

Min is actively involved in mentoring, training and supervising research students and fellows. He currently serves as Associate Editor (Global Health) for Kidney and Blood Pressure Research and has been involved in the development of clinical practice guidelines for the care of patients with kidney disease in Australia and internationally.

Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial

Nephrology Dialysis Transplantation Date published:

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

Diabetes, Obesity and Metabolism Date published:

Trends in publicly subsidized and private access to GLP-1 medicines indicated for type 2 diabetes in Australia, 2020-2025

British Journal of Clinical Pharmacology Date published:

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease

JAMA Date published:

Related Readings